198 related articles for article (PubMed ID: 37919824)
21. c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice.
Rao G; Pedone CA; Coffin CM; Holland EC; Fults DW
Neoplasia; 2003; 5(3):198-204. PubMed ID: 12869303
[TBL] [Abstract][Full Text] [Related]
22. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
[TBL] [Abstract][Full Text] [Related]
23. A mouse model of the most aggressive subgroup of human medulloblastoma.
Kawauchi D; Robinson G; Uziel T; Gibson P; Rehg J; Gao C; Finkelstein D; Qu C; Pounds S; Ellison DW; Gilbertson RJ; Roussel MF
Cancer Cell; 2012 Feb; 21(2):168-80. PubMed ID: 22340591
[TBL] [Abstract][Full Text] [Related]
24. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.
Dey A; Robitaille M; Remke M; Maier C; Malhotra A; Gregorieff A; Wrana JL; Taylor MD; Angers S; Kenney AM
Oncogene; 2016 Aug; 35(32):4256-68. PubMed ID: 26725322
[TBL] [Abstract][Full Text] [Related]
25. BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.
Henssen A; Thor T; Odersky A; Heukamp L; El-Hindy N; Beckers A; Speleman F; Althoff K; Schäfers S; Schramm A; Sure U; Fleischhack G; Eggert A; Schulte JH
Oncotarget; 2013 Nov; 4(11):2080-95. PubMed ID: 24231268
[TBL] [Abstract][Full Text] [Related]
26. Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts.
Pöschl J; Stark S; Neumann P; Gröbner S; Kawauchi D; Jones DT; Northcott PA; Lichter P; Pfister SM; Kool M; Schüller U
Acta Neuropathol; 2014 Jul; 128(1):123-36. PubMed ID: 24871706
[TBL] [Abstract][Full Text] [Related]
27. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
[TBL] [Abstract][Full Text] [Related]
28. Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes.
Yoon JW; Gilbertson R; Iannaccone S; Iannaccone P; Walterhouse D
Int J Cancer; 2009 Jan; 124(1):109-19. PubMed ID: 18924150
[TBL] [Abstract][Full Text] [Related]
29. Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression.
Milla LA; Arros A; Espinoza N; Remke M; Kool M; Taylor MD; Pfister SM; Wainwright BJ; Palma V
Int J Cancer; 2014 Jan; 134(1):21-31. PubMed ID: 23775842
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma.
Robinson MH; Maximov V; Lallani S; Farooq H; Taylor MD; Read RD; Kenney AM
Sci Rep; 2019 Sep; 9(1):13611. PubMed ID: 31541170
[TBL] [Abstract][Full Text] [Related]
31. Mitogenic Sonic hedgehog signaling drives E2F1-dependent lipogenesis in progenitor cells and medulloblastoma.
Bhatia B; Hsieh M; Kenney AM; Nahlé Z
Oncogene; 2011 Jan; 30(4):410-22. PubMed ID: 20890301
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
[TBL] [Abstract][Full Text] [Related]
33. N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma.
Browd SR; Kenney AM; Gottfried ON; Yoon JW; Walterhouse D; Pedone CA; Fults DW
Cancer Res; 2006 Mar; 66(5):2666-72. PubMed ID: 16510586
[TBL] [Abstract][Full Text] [Related]
34. Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine.
Moreira DC; Venkataraman S; Subramanian A; Desisto J; Balakrishnan I; Prince E; Pierce A; Griesinger A; Green A; Eberhardt CG; Foreman NK; Vibhakar R
J Neurooncol; 2020 May; 147(3):531-545. PubMed ID: 32180106
[TBL] [Abstract][Full Text] [Related]
35. Role of MXD3 in proliferation of DAOY human medulloblastoma cells.
Barisone GA; Ngo T; Tran M; Cortes D; Shahi MH; Nguyen TV; Perez-Lanza D; Matayasuwan W; Díaz E
PLoS One; 2012; 7(7):e38508. PubMed ID: 22808009
[TBL] [Abstract][Full Text] [Related]
36. Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation.
Kutscher LM; Okonechnikov K; Batora NV; Clark J; Silva PBG; Vouri M; van Rijn S; Sieber L; Statz B; Gearhart MD; Shiraishi R; Mack N; Orr BA; Korshunov A; Gudenas BL; Smith KS; Mercier AL; Ayrault O; Hoshino M; Kool M; von Hoff K; Graf N; Fleischhack G; Bardwell VJ; Pfister SM; Northcott PA; Kawauchi D
Genes Dev; 2020 Sep; 34(17-18):1161-1176. PubMed ID: 32820036
[TBL] [Abstract][Full Text] [Related]
37. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
[TBL] [Abstract][Full Text] [Related]
38. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem.
Grammel D; Warmuth-Metz M; von Bueren AO; Kool M; Pietsch T; Kretzschmar HA; Rowitch DH; Rutkowski S; Pfister SM; Schüller U
Acta Neuropathol; 2012 Apr; 123(4):601-14. PubMed ID: 22349907
[TBL] [Abstract][Full Text] [Related]
39. CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma.
Dahlin AM; Hollegaard MV; Wibom C; Andersson U; Hougaard DM; Deltour I; Hjalmars U; Melin B
J Neurooncol; 2015 Oct; 125(1):75-8. PubMed ID: 26290144
[TBL] [Abstract][Full Text] [Related]
40.
Concepcion CP; Ma S; LaFave LM; Bhutkar A; Liu M; DeAngelo LP; Kim JY; Del Priore I; Schoenfeld AJ; Miller M; Kartha VK; Westcott PMK; Sánchez-Rivera FJ; Meli K; Gupta M; Bronson RT; Riely GJ; Rekhtman N; Rudin CM; Kim CF; Regev A; Buenrostro JD; Jacks T
Cancer Discov; 2022 Feb; 12(2):562-585. PubMed ID: 34561242
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
